financetom
Business
financetom
/
Business
/
Lazard Tender Offer Draws $235.7 Million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lazard Tender Offer Draws $235.7 Million
Mar 13, 2024 6:56 AM

09:23 AM EDT, 03/13/2024 (MT Newswires) -- Lazard ( LAZ ) said Wednesday that the cash tender offer for 3.75% senior notes due Feb. 13, 2025 by its Lazard Group unit expired Tuesday.

The company said approximately $235.7 million worth of the notes were validly tendered and not withdrawn.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Timing for US ether ETF launches depends on how fast issuers can move, SEC chair says
Timing for US ether ETF launches depends on how fast issuers can move, SEC chair says
Jun 5, 2024
(Reuters) - The timing for when exchange-traded funds (ETFs) tied to the cryptocurrency ether can begin trading depends largely on how quickly issuers respond to the U.S. Securities and Exchange Commission's queries, Chair Gary Gensler said on Wednesday. The SEC last month approved applications from Nasdaq, CBOE and NYSE to list spot ether ETFs. It was a surprise win for...
FOCUS-Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
FOCUS-Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
Jun 5, 2024
SHANGHAI, June 6 (Reuters) - Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight loss treatment Wegovy, clinical trial records showed. The Danish drugmaker has high hopes that demand for its blockbuster drugs will surge in China, which is...
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
Jun 5, 2024
SHANGHAI (Reuters) - Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are developing at least 15 generic versions of its diabetes drug Ozempic and weight loss treatment Wegovy, clinical trial records showed. The Danish drugmaker has high hopes that demand for its blockbuster drugs will surge in China, which is estimated to...
Mexico's Sheinbaum to prioritize public internet access, adviser says
Mexico's Sheinbaum to prioritize public internet access, adviser says
Jun 5, 2024
MEXICO CITY, June 5 (Reuters) - Mexican President-elect Claudia Sheinbaum is set to prioritize public internet access after taking office, an adviser said on Wednesday. Jose Merino, an adviser to Sheinbaum on digital strategy, told a telecoms conference in Mexico City that the state must reach areas of the country that private telecoms companies do not cover, underscoring her intention...
Copyright 2023-2026 - www.financetom.com All Rights Reserved